ARM 24.174.1706. REGISTRY INFORMATION REVIEW AND UNSOLICITED PATIENT PROFILES

(1) The board or their designee(s) may review and compile information contained in the registry to identify evidence of possible misuse or diversion of controlled substances. (2) Registered prescribers and pharmacists will be notified electronically, through vendor functionality, of instances of possible misuse or diversion for patients under their care (3) The following factors are suggestive, but not conclusive evidence of misuse or diversion: (a) four or more prescribers in a 60-day period; or (b) four or more pharmacies in a 60-day period.